Jason Lamontagne

1.1k total citations
20 papers, 756 citations indexed

About

Jason Lamontagne is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Jason Lamontagne has authored 20 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Oncology. Recurrent topics in Jason Lamontagne's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis C virus research (5 papers). Jason Lamontagne is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis C virus research (5 papers). Jason Lamontagne collaborates with scholars based in United States, Canada and United Kingdom. Jason Lamontagne's co-authors include Michael J. Bouchard, Sumedha Bagga, Timothy M. Block, Xuanyong Lu, Young Bok Kang, Joshua Chang Mell, Mark H. Pinkerton, Laura F. Steel, Jenny A. Greig and James M. Wilson and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Journal of Virology.

In The Last Decade

Jason Lamontagne

20 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Lamontagne United States 16 284 266 206 140 119 20 756
Cheng‐Po Hu Taiwan 16 217 0.8× 283 1.1× 148 0.7× 182 1.3× 22 0.2× 27 699
Florence Levillayer France 16 161 0.6× 388 1.5× 90 0.4× 91 0.7× 24 0.2× 21 743
Masaki Iwai Japan 15 105 0.4× 316 1.2× 142 0.7× 56 0.4× 36 0.3× 38 711
Bettina Mundt Germany 9 219 0.8× 503 1.9× 127 0.6× 183 1.3× 13 0.1× 13 841
Diana Llópiz Spain 19 103 0.4× 351 1.3× 92 0.4× 518 3.7× 40 0.3× 34 1.2k
Sudhasri Mohanty United States 13 79 0.3× 451 1.7× 54 0.3× 94 0.7× 27 0.2× 16 863
Janet L. DeMayo United States 9 238 0.8× 836 3.1× 264 1.3× 147 1.1× 14 0.1× 9 1.7k
Chuanshan Zhang China 17 75 0.3× 224 0.8× 32 0.2× 206 1.5× 19 0.2× 60 1.1k
Zhanying Hu China 18 427 1.5× 232 0.9× 250 1.2× 111 0.8× 3 0.0× 28 794
Riki Perlman Israel 13 71 0.3× 577 2.2× 25 0.1× 216 1.5× 14 0.1× 31 832

Countries citing papers authored by Jason Lamontagne

Since Specialization
Citations

This map shows the geographic impact of Jason Lamontagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Lamontagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Lamontagne more than expected).

Fields of papers citing papers by Jason Lamontagne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Lamontagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Lamontagne. The network helps show where Jason Lamontagne may publish in the future.

Co-authorship network of co-authors of Jason Lamontagne

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Lamontagne. A scholar is included among the top collaborators of Jason Lamontagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Lamontagne. Jason Lamontagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hordeaux, Juliette, et al.. (2025). Lung endothelial transduction in a patient that succumbed to acute respiratory distress syndrome following high-dose rAAV9 gene therapy. Molecular Therapy. 33(6). 2339–2342. 1 indexed citations
2.
Aras, Shweta, Ashleigh Morgan, Nesteene J. Param, et al.. (2024). Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis. Cancer Gene Therapy. 31(5). 766–777. 1 indexed citations
3.
Hordeaux, Juliette, Jason Lamontagne, Chunjuan Song, et al.. (2024). High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury. Molecular Therapy. 32(4). 952–968. 27 indexed citations
4.
Greig, Jenny A., Camilo Breton, Jason Lamontagne, et al.. (2023). Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nature Biotechnology. 42(8). 1232–1242. 73 indexed citations
5.
Su, Chenhe, Fang Lü, Samantha S. Soldan, et al.. (2021). EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. PLoS Pathogens. 17(8). e1009834–e1009834. 12 indexed citations
6.
Lamontagne, Jason, Samantha S. Soldan, Chenhe Su, et al.. (2021). A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. PLoS Pathogens. 17(1). e1009208–e1009208. 28 indexed citations
7.
Soldan, Samantha S., Chenhe Su, Jason Lamontagne, et al.. (2021). Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes. PLoS Pathogens. 17(6). e1009618–e1009618. 25 indexed citations
8.
Wang, Renxue, Jonathan A. Sheps, Lin Liu, et al.. (2018). Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2 mice. Journal of Lipid Research. 60(1). 85–97. 31 indexed citations
9.
10.
Lamontagne, Jason, et al.. (2017). Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes. PLoS ONE. 12(2). e0168328–e0168328. 26 indexed citations
11.
Lamontagne, Jason, Joshua Chang Mell, & Michael J. Bouchard. (2016). Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression. PLoS Pathogens. 12(2). e1005438–e1005438. 49 indexed citations
12.
Mehta, Anand S., Mary Ann Comunale, Siddhartha Rawat, et al.. (2016). Intrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylation. Scientific Reports. 6(1). 27965–27965. 29 indexed citations
13.
Lamontagne, Jason, Sumedha Bagga, & Michael J. Bouchard. (2016). Hepatitis B virus molecular biology and pathogenesis. Hepatoma Research. 2(7). 163–163. 125 indexed citations
14.
Lamontagne, Jason. (2015). Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World Journal of Gastroenterology. 21(24). 7375–7375. 53 indexed citations
15.
Kang, Young Bok, et al.. (2015). Liver sinusoid on a chip: Long‐term layered co‐culture of primary rat hepatocytes and endothelial cells in microfluidic platforms. Biotechnology and Bioengineering. 112(12). 2571–2582. 129 indexed citations
16.
17.
Lamontagne, Jason, et al.. (2011). Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis. Immunology. 134(4). 398–408. 19 indexed citations
18.
Lamontagne, Jason, Mark H. Pinkerton, Timothy M. Block, & Xuanyong Lu. (2009). Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis. Journal of Virology. 84(2). 907–917. 32 indexed citations
19.
Lu, Xuanyong, et al.. (2008). Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis. APOPTOSIS. 13(4). 483–494. 23 indexed citations
20.
Hourdez, Stéphane, et al.. (2000). Hemoglobin from a deep-sea hydrothermal-vent copepod. Biological Bulletin. 199(2). 95–99. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng‐Po Hu Breakdown of academic impact, for papers by Florence Levillayer Breakdown of academic impact, for papers by Masaki Iwai Breakdown of academic impact, for papers by Bettina Mundt Breakdown of academic impact, for papers by Diana Llópiz Breakdown of academic impact, for papers by Sudhasri Mohanty Breakdown of academic impact, for papers by Janet L. DeMayo Breakdown of academic impact, for papers by Chuanshan Zhang Breakdown of academic impact, for papers by Zhanying Hu Breakdown of academic impact, for papers by Riki Perlman
Rankless by CCL
2026